29,929 results on '"Blood Coagulation Disorders"'
Search Results
2. Storytelling for Reducing Gap in Anticoagulation Use in African Americans With Atrial Fibrillation
3. Adjusted Fibrinogen Replacement Strategy (AdFIrst)
4. Investigation of the Genetics of Hematologic Diseases
5. Evaluation of TEG 6S PM® During Cardiopulmonary Bypass to Detect Postoperative Biological Coagulopathy (PREDIPOC)
6. Personalized ViscoElastic Testing-guided Bleeding Management in Liver Surgery, Neurosurgery and Obstetrics (VETILNO)
7. Quantra Point-of-Care Hemostasis Monitoring (QUANTRA)
8. SWIFT - SWIss Factor XIII Trial in PPH (SWIFT)
9. Recombinant VWF Concentrate and ECMO
10. Rifaximin in Cirrhosis: Effects on Endotoxin and Haemostatic Indexes
11. Evaluation of Clinical Ranges of Whole Blood Clotting Times of Patients on Anticoagulants
12. Validation of Point-of-care Thromboelastography (TEG 6s) in Pediatric Patients
13. Study of TU7710 in Warfarin Anti-coagulated Healthy Male Subjects
14. ATHN Transcends: A Natural History Study of Non-Neoplastic Hematologic Disorders
15. Gene Therapy Study in Severe Hemophilia a Patients with Antibodies Against AAV5 (GENEr8-AAV5+)
16. The Utility of Thromboelastography in Traumatic Brain Injury
17. Safety and Feasibility of Argatroban As Anticoagulant in Adults with ECMO
18. Frequency, Predictors and Outcome of Sepsis Induced Coagulopathy in Critical Care Unit
19. Pre-hospital Administration of Fibrinogen in Trauma-Induced Coagulopathy (PAF-TIC)
20. Markers of Inflammation and of the Pro-thrombotic State in Hospital Shift and Day Workers (IPNO)
21. Study for Turoctocog Alfa Treatment Regimen in Iraqi Haemophilia A Patients
22. Coagulation Disorders Secondary to Two Plasmapheresis Techniques (Double Filtration Plasmapheresis vs. PFS). Descriptive Pilot Study. (APHERCOAG)
23. Extracellular Vesicles and Dysregulated Coagulation in the Prediction of Stroke (PREDICT-EV)
24. Effects of VMX-C001 on the Anticoagulant Effect of Different Forms of Heparin
25. The Safety, Tolerability, Pharmacokinetics, and Preliminary Efficacy of HMPL-523 in Adult Subjects With Immune Thrombocytopenia (ITP)
26. A Study of TAK-330 to Reverse the Effects of Factor Xa Inhibitors For Adults Needing Urgent Surgery
27. A Study to Evaluate the Safety, PK/PD of (OriCAR-017) in Subjects With RR/MM - RIGEL Study
28. Extracorporeal Life Support and Modification of Hemostasis (ELMOH)
29. Evolution of Coagulation Activity in Non Valvular Atrial Fibrillation Patients Under Apixaban (ECAN)
30. Single Dose Trial of VMX-C001 in Healthy Subjects With and Without FXa Direct Oral Anticoagulant
31. Pharmacokinetics, Pharmacodynamics, and Safety Profile of Understudied Drugs Administered to Children Per Standard of Care (POPS) (POPS or POP02)
32. The Effect of Exercise on Pharmacodynamics and Pharmacokinetics of a Single Dose of Unfractionated Heparin
33. Left Atrial Appendage Occlusion for AF Patients Unable to Use Oral Anticoagulation Therapy (COMPARE-LAAO)
34. TRanEXamic Acid to Decrease Heavy Menstrual Bleeding in Individuals Anticoagulated for Venous Thromboembolism Pilot Study (T-REX HMB)
35. CPP Versus PFC to Correct Coagulation Disorders in Adult Neurosurgical Patients (CLOT-CRANE)
36. Comparison of Rapid-, Kaolin-, and Native-TEG Parameters in Burn Patient Cohorts With Acute Burn-induced Coagulopathy and Abnormal Fibrinolytic Function.
37. Heparin Reversal With Two Different Protamine Ratios After Cardiopulmonary By-pass.
38. Post Marketing Observational Study on Safety of BALFAXAR vs. KCENTRA for Reversal of Vitamin K Antagonist Induced Anticoagulation in Adults Undergoing Urgent Surgery or Invasive Procedure
39. Comparison of Viscoelastic Measurement by ROTEM® Delta and ClotPro® in Trauma Patients. (ROTCLOT)
40. Caudal Block & Hip Fracture Surgery in Anticoagulated Patient
41. Caudal Analgesia & Anticoagulated Patient
42. Quantra® System With the QStat® Cartridge in Trauma
43. Quantra QStat Sample Type Comparison
44. MAC Project, Monitoring of AntiCoagulant Therapies (MAC) (MAC)
45. IV Ketorolac on Platelet Function Post-Cesarean Delivery (KetoPltAgg)
46. Transfusion Surveillance in Anaesthesia (STAR)
47. RAS and Coagulopathy in COVID19
48. The Diagnostic and Prognostic Value of TAT, PIC, tPAI·C and TM in Sepsis-induced Coagulopathy
49. Dynamics of Platelet Activation in Patients With Ventricular Assist Device (VAD) (PASVAD)
50. Establishment of Risk Factors Model of Drug-induced Coagulation Disorder Caused by Cefoperazone Sulbactam Sodium
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.